Literature DB >> 28516208

Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation.

Nassrine Bachsais1, Lila Boussag-Abib1, Fatima Laraba-Djebari2.   

Abstract

OBJECTIVE: The efficiency and safety of vaccine are the most important properties, however, as any medication, it can induce side effects. This prophylactic therapy could be used to prevent the lethal and pathophysiological effects induced after scorpion envenomation.
METHODS: In this study, detoxified venom associated to alum adjuvant (V*alum) is used as a vaccine against scorpion venom for immunization of mice. We evaluate the safety and the inflammatory response of this vaccine. We also investigated the protective effect of this formulation against the toxicity of native Androctonus australis hector venom.
RESULTS: Results showed no adverse events occurred after immunization of animals. This active immunization of animals did not cause change in vascular permeability, no edema formation in the studied organs. Furthermore, there are no IgE production in sera, nor change in the morphology of the mast cells in skin tissues. However, low inflammatory response triggered by activating the recruitment of eosinophils associated to IL-4 and IL-5 release was observed. All immunized animals are protected from the toxic effects of native venom until 6 LD50 and to 7 LD50 after the second challenge.
CONCLUSION: This safe vaccine preparation seems to induce a long-term protection without any risk of deleterious inflammatory response.

Entities:  

Keywords:  Active immunization; Immunoprotection; Inflammatory response; Safety

Mesh:

Substances:

Year:  2017        PMID: 28516208     DOI: 10.1007/s00011-017-1055-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  43 in total

Review 1.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 2.  An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity.

Authors:  Tetsuo Nakayama
Journal:  Vaccine       Date:  2016-10-13       Impact factor: 3.641

3.  Contact sensitivity to aluminium.

Authors:  K Böhler-Sommeregger; H Lindemayr
Journal:  Contact Dermatitis       Date:  1986-11       Impact factor: 6.600

4.  Pharmacological evidence that neuropeptides mediate part of the actions of scorpion venom on the guinea pig ileum.

Authors:  I M Matos; M M Teixeira; R Leite; L Freire-Maia
Journal:  Eur J Pharmacol       Date:  1999-03-05       Impact factor: 4.432

5.  A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.

Authors:  X M Li; D Serebrisky; S Y Lee; C K Huang; L Bardina; B H Schofield; J S Stanley; A W Burks; G A Bannon; H A Sampson
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

6.  Stimulation of degranulation from human eosinophils by platelet-activating factor.

Authors:  C Kroegel; T Yukawa; G Dent; P Venge; K F Chung; P J Barnes
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

Review 7.  Non-allergic eosinophilic inflammation.

Authors:  Ugur Gonlugur; Tanseli Efeoglu Gonlugur
Journal:  Immunol Invest       Date:  2006       Impact factor: 3.657

8.  Enhancement of long-lasting immunoprotective effect against Androctonus australis hector envenomation using safe antigens: Comparative role of MF59 and Alum adjuvants.

Authors:  Abdelmounaim Nouri; Fatima Laraba-Djebari
Journal:  Vaccine       Date:  2015-09-28       Impact factor: 3.641

9.  IL-4 is required to generate and sustain in vivo IgE responses.

Authors:  F D Finkelman; I M Katona; J F Urban; J Holmes; J Ohara; A S Tung; J V Sample; W E Paul
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

10.  APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.

Authors:  Elodie Belnoue; Maria Pihlgren; Tracy L McGaha; Chantal Tougne; Anne-Françoise Rochat; Claudia Bossen; Pascal Schneider; Bertrand Huard; Paul-Henri Lambert; Claire-Anne Siegrist
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.